Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.85B |
| 2 |
Linde
LIN
|
+$1.14B |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$653M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$629M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$591M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.17B |
| 2 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$981M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$416M |
| 4 |
Amazon
AMZN
|
+$402M |
| 5 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$338M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.9% |
| 2 | Healthcare | 5.31% |
| 3 | Financials | 5.25% |
| 4 | Communication Services | 4.61% |
| 5 | Consumer Discretionary | 4.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3501
Silgan Holdings
SLGN
$4.46B
| $651K | ﹤0.01% |
27,611
-31,297
| -53% | -$787K |
|
3502
Minerals Technologies
MTX
$2.26B
| $650K | ﹤0.01% |
12,672
-25,805
| -67% | -$1.44M |
|
|
CLVS
3503
PUT
DELISTED
Clovis Oncology, Inc.
CLVS
| $650K | ﹤0.01% |
36,200
-3,100
| -8% | -$63.3K |
|
3504
PUT
Direxion Daily Junior Gold Miners Index Bull 2X ETF
JNUG
$516M
| $649K | ﹤0.01% |
1,410
-812
| -37% | -$315K |
|
3505
Invesco S&P 500 Equal Weight ETF
RSP
$100B
| $649K | ﹤0.01% |
7,107
+1,500
| +27% | +$149K |
|
|
BECN
3506
DELISTED
Beacon Roofing Supply, Inc.
BECN
| $649K | ﹤0.01% |
20,470
-12,964
| -39% | -$400K |
|
3507
Collegium Pharmaceutical
COLL
$913M
| $648K | ﹤0.01% |
37,707
+26,688
| +242% | +$457K |
|
3508
TTM Technologies
TTMI
$14.6B
| $648K | ﹤0.01% |
66,563
-246,659
| -79% | -$3.02M |
|
|
FTSI
3509
DELISTED
FTS International, Inc. Common Stock
FTSI
| $648K | ﹤0.01% |
4,552
+837
| +23% | +$176K |
|
3510
CALL
Direxion Daily S&P 500 Bull 3x ETF
SPXL
$7.41B
| $645K | ﹤0.01% |
19,600
+10,400
| +113% | +$443K |
|
3511
Archrock
AROC
$5.85B
| $644K | ﹤0.01% |
85,852
-77,177
| -47% | -$782K |
|
3512
PUT
Cal-Maine
CALM
$3.87B
| $643K | ﹤0.01% |
15,200
+2,800
| +23% | +$130K |
|
3513
PUT
Range Resources
RRC
$9.33B
| $643K | ﹤0.01% |
67,200
-11,200
| -14% | -$170K |
|
3514
Cinemark Holdings
CNK
$4.37B
| $642K | ﹤0.01% |
17,919
-28,162
| -61% | -$1.11M |
|
3515
FormFactor
FORM
$10.3B
| $641K | ﹤0.01% |
45,456
-60,462
| -57% | -$843K |
|
3516
KRONOS Worldwide
KRO
$996M
| $641K | ﹤0.01% |
55,622
-10,255
| -16% | -$138K |
|
3517
NBT Bancorp
NBTB
$2.79B
| $641K | ﹤0.01% |
18,513
-31,861
| -63% | -$1.17M |
|
|
HZNP
3518
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $640K | ﹤0.01% |
32,742
-122,012
| -79% | -$2.39M |
|
3519
Park Hotels & Resorts
PK
$3.03B
| $637K | ﹤0.01% |
24,525
-503,482
| -95% | -$14.9M |
|
3520
ATN International
ATNI
$491M
| $636K | ﹤0.01% |
8,891
-5,947
| -40% | -$465K |
|
|
CUK
3521
DELISTED
Carnival PLC
CUK
| $636K | ﹤0.01% |
13,060
+12,163
| +1,356% | +$689K |
|
3522
Matthews International
MATW
$722M
| $636K | ﹤0.01% |
15,654
-23,708
| -60% | -$1.01M |
|
|
AXE
3523
DELISTED
Anixter International Inc
AXE
| $636K | ﹤0.01% |
11,694
-24,458
| -68% | -$1.54M |
|
3524
ACI Worldwide
ACIW
$5.42B
| $635K | ﹤0.01% |
22,956
-88,534
| -79% | -$2.4M |
|
|
ZGNX
3525
DELISTED
Zogenix, Inc.
ZGNX
| $635K | ﹤0.01% |
17,409
-21,218
| -55% | -$869K |
|
Similar funds
Barclays's Q4 2018 Portfolio in Review
As of Q4 2018, Barclays held 7,834 positions worth $129B, down 10% from $144B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Barclays deployed $5.69B of net new capital in Q4 2018, opening 489 new positions and adding to 2,471 existing holdings. Its largest new stake was Linde: 7,232,686 shares worth $1.13B.
By sector, the portfolio is most concentrated in Technology at 6.9% of assets, down from 8.2% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Fortive, an estimated $1.17B trimmed.
- Barclays's largest Q4 2018 buy was Linde: 7,232,686 shares worth $1.13B.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q4 2018, an estimated $1.85B increase.
- Barclays's biggest Q4 2018 reduction was Fortive, cutting an estimated $1.17B.
- Barclays fully exited Energy Transfer Partners, L.P. in Q4 2018, selling an estimated $184M.
- Barclays's ten largest holdings make up 32% of its $129B portfolio in Q4 2018.
- Barclays opened 489 new positions and closed 777 in Q4 2018.
- Barclays's portfolio value fell 10% quarter-over-quarter to $129B.
Based on Barclays's 13F filing for Q4 2018, filed 14 Feb 2019.